Market Talk: Ceasefire Hopes Outweigh Tariff Concerns, US Recession Outlook

Market Reaction to Tariffs and Ceasefire Hopes

• 📈 US futures indicate a positive open for Wall Street, influenced by a mix of tariff news and potential ceasefire developments.
• ⚠️ While Trump's 25% tariffs on steel and aluminum imports are seen as less severe than feared, they are expected to increase inflation in both Europe and the US.
• 🌍 Europe plans to impose counter-tariffs on up to 26 billion euros of US goods, signaling a potential escalation of the trade war.
• 🕊️ Hopes for a ceasefire in Ukraine are currently dominating market sentiment, lifting spirits after recent volatility and sell-offs.

US Recession Outlook

• 📊 Joachim Klement does not foresee a US recession in 2025, citing the economy's strong momentum and growth.
• 📉 However, rising inflation pressures are expected to cause a slowdown in the US economy, potentially pushing it towards a recession brink in 2026.
• ⚠️ A massive escalation of the trade war is identified as a key factor that could accelerate a recession.

Novo Nordisk and Obesity Drug Deals

• 💊 Roche has entered into a significant $5.3 billion licensing agreement for a next-generation obesity drug developed by Zealand Pharma.
• 💰 This deal provides Roche access to a potentially successful weight-loss treatment, though the numbers are substantial and favor Zealand Pharma.
• ⏳ The drug is currently in Phase 1/2 trials, with market entry anticipated in the late 2020s or early 2030s.
• 🔬 By the time the drug is available, the market is expected to be crowded with competitors, including those from AstraZeneca, while Novo Nordisk and Eli Lilly may remain unchallenged in the short term.